Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenotypic and Genetic Correlates of Diabetes in Young Non-Obese Asian Indians and Sitagliptin Efficacy
NCT00964184Phase 4Completed
- Sponsor
- Diabetes Foundation
- Start
- Sep 2009
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Diabetes Foundation. Primary endpoint: Glycated Hemoglobin at 12 weeks. Started Sep 2009; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00964184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00964184.